GLP-1 agonists do seem like a genuine medical breakthrough. In managing type 2 diabetes, but also across multiple specialities. I was talking to a neurologist the other day and they were saying that apparently they were seeing reductions in peripheral neuropathy even in non diabetics and they weren't sure how or why.
It's just that we live under shitty sclerotic late stage capitalism that they've become the celebrity weight loss drug and might harm a bunch of people through side effects to do systemic medical and societal fatphobia.
GLP-1 agonists do seem like a genuine medical breakthrough. In managing type 2 diabetes, but also across multiple specialities. I was talking to a neurologist the other day and they were saying that apparently they were seeing reductions in peripheral neuropathy even in non diabetics and they weren't sure how or why.
It's just that we live under shitty sclerotic late stage capitalism that they've become the celebrity weight loss drug and might harm a bunch of people through side effects to do systemic medical and societal fatphobia.